2024 CACLP
The 21st China International Medical Laboratory Equipment and Reagent Exhibition (CACLP) concluded successfully on March 18 (from March 16), 2024. As one of the outstanding potential stocks in the POCT industry, We, Wizbiotech had a wonderful appearance as a supplier of POCT system solutions, showcasing 8 major fields’ products and receiving unanimous praise.
Creating POCT System Solutions with Diverse Offerings
Wizbiotech has gone through a decade-long journey, seizing development opportunities and keeping pace with the time changes. We have focused on eight major fields, including the digestive system, respiratory system, and tumors, and have developed and produced over 100 test-kit products and multiple immunological analyzers, contributing to various applications in grassroots medical care and clinical diagnosis and treatment. Our past achievements are the foundation and continuation of the future. As a company that adheres to long-termism, Wizbiotech took part in the exhibition as a supplier of POCT system solutions, and is ready to embrace new changes.
One hand, Wizbiotech will strengthen research and development investment, build a strong innovation engine, and continuously improve the product system centered around POCT; Another hand, we will start from the perspective of doctors and patients, driven by demand, based on the industry, and led by innovation, with sustainable development as the goal. We will deeply explore various pain points and difficulties in medical services, disease prevention, health management, chronic disease management, and hierarchical diagnosis and treatment, and provide solutions that better meet market demands.
New Product Launches Boost the POCT Industry to New Heights
Wizbiotech has received approvals for seven new products, including the Troponin I/occult blood detection reagent kit (colloidal gold method), the insulin assay kit, C-peptide assay kit, ferritin assay kit, anti-Müllerian hormone assay kit, heparin-binding protein assay kit, and the pepsinogen I/pepsinogen II/gastrin-17 assay kit (these are with fluorescence immunochromatographic method).
The launch of these seven new products signifies the recognition of Wizbiotech’s research and development power in the field of POCT, providing more choices and possibilities for auxiliary diagnosis in the medical field. They will continue to help improving the accuracy and efficiency of diagnostics, benefiting more patients.
Wizbiotech Booth: Enthusiastic and Dynamic
At the exhibition, the Wizbiotech’s team did not only showcased their products and services but also demonstrated the team’s strength and professionalism through interactive communication with other exhibitors and participants. We promoted common progress in the industry, recorded valuable market feedback and user needs, shared our unique insights towards the industry, and established a good brand and corporate image.
This exhibition did not only show Wizbiotech’s strength as a supplier of POCT system solutions but also represented a firm commitment to future development. On the road ahead, Wizbiotech will continue to adhere to technological innovation, continuously strengthen independent research and development capabilities, enhance market development efforts, meet the ever-changing needs of customers, promote products’ upgrades and optimization, improve customer experience, and provide more reliable, convenient, intelligent, and efficient POCT solutions, to safeguard people’s health.
